Emerging World Pharma Inc. Strategic Partner African Global Pharma Forms Exclusive Marketing and Distribution Agreement With the
07 4월 2010 - 1:15AM
Marketwired
Emerging World Pharma Inc. (PINKSHEETS: EWPI), an investor in
generic based pharmaceutical companies manufacturing within
developing nations, announces that African Global Pharma Ghana Ltd
has formed an exclusive marketing and distribution agreement with
the Catholic Diocese of Sunyani, Ghana. Emerging World Pharma had
earlier provided an investment into African Global Pharma and has
an option to increase their investment and percentage of profits by
up to 25%.
The Diocese of Sunyani will be the sole distributor for all the
drugs manufactured by African Global Pharma Ghana Ltd. This
strategic partnership will allow priority access to Catholic
Mission Hospitals in Ghana, West Africa and the rest of the African
continent.
African Global Pharma will produce a variety of medicines
including, antibiotics and anti-malarials. There are a total of
thirteen different medicines to begin production with a further
eighteen to be registered later on as production capacity is
expanded.
The Diocese of Sunyani will also market AGP products to other
private and public hospitals and pharmacies. Ghana acts as the
gateway to a huge sub-regional market of over 250 million
people.
The partnership will also include the eventual opening of a
research facility to be determined and approved by the board at the
University of the Diocese. The focus will be on the research and
development for new medicines and for the training of students in
this pharmacological field.
Emerging World Pharma company president, Brandon Keks is
returning to Africa this week to further assess progress of the
generic drug manufacturing facilities and to continue business
relations with African Global Pharma Inc. "I am told that the
production facilities are right on schedule and that equipment will
be set up and test runs will begin in the next few weeks," added
Keks.
www.emergingpharma.com
About Emerging World Pharma Inc.
Emerging World Pharma Inc. is an investor in generic based
pharmaceutical companies manufacturing within developing
nations.
The company focuses its investments on generic pharmaceutical
companies that have contracts with three major buyer groups;
church, government and wholesalers. Market research shows that
these branches are the most secure, protected and reputable for the
distribution of medicines.
Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. Statements in this release that are forward-looking
statements are based on current expectations and assumptions that
are subject to known and unknown risks, uncertainties, or other
factors which may cause actual results, performance, or
achievements of the company to be materially different from any
future results, performance, or achievements expressed or implied
by such forward-looking statements. Actual results could differ
materially because of factors such as the effect of general
economic and market conditions, entry into markets with vigorous
competition, market acceptance of new products and services,
continued acceptance of existing products and services,
technological shifts, and delays in product development and related
product release schedules, any of which may cause revenues and
income to fall short of anticipated levels. All information in this
release is as of the date of this release. The company undertakes
no duty to update any forward-looking statement to conform the
statement to actual results or changes in the company's
expectations.
Contact: Joel Everret Emerging World Pharma Inc. Investor
Relations Division 703-646-2633 Email: info@emergingpharma.com
Emerging World Pharma (CE) (USOTC:EWPI)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Emerging World Pharma (CE) (USOTC:EWPI)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024